APA (7th ed.) Citation

Preusch MR, Ieronimakis N, Wijelath ES, Cabbage S, Ricks J, Bea F, . . . Rosenfeld ME. (2015). Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice. Dove Medical Press.

Chicago Style (17th ed.) Citation

Preusch MR, Ieronimakis N, Wijelath ES, Cabbage S, Ricks J, Bea F, Reyes M, van Ryn J, and Rosenfeld ME. Dabigatran Etexilate Retards the Initiation and Progression of Atherosclerotic Lesions and Inhibits the Expression of Oncostatin M in Apolipoprotein E-deficient Mice. Dove Medical Press, 2015.

MLA (9th ed.) Citation

Preusch MR, et al. Dabigatran Etexilate Retards the Initiation and Progression of Atherosclerotic Lesions and Inhibits the Expression of Oncostatin M in Apolipoprotein E-deficient Mice. Dove Medical Press, 2015.